regulatory arbitrage
Shifting financial activity to less-regulated areas to avoid the cost of regulation, potentially undermining its intent.
As defined in cwt_austan-goolsbee
Other definitions
Structuring activities or assets to exploit differences in regulatory capital treatment, obtaining favorable treatment that does not reflect true risk.
Riccardo Rebonato on Risk Management and the Crisis 06/08/2009Exploiting differences or gaps in regulation across jurisdictions to gain an economic advantage
Hash Power – Part 2
Where it comes up · 20
- Tim Harford on the Virtues of Disorder and Messy3 claims
- Making Sense of Markets in a Post Election World | Grant Wiliams and Ben Hunt2 claims
- Michael Howell's Liquidity Framework: Why Bitcoin Is Winning & Will Keep Winning2 claims
- Kenneth Rogoff on Monetary Moves, Fiscal Gambits, and Classical Chess | Conversations with Tyler2 claims
- Peter Thiel on Political Theology | Conversations with Tyler2 claims
- Collateral Crisis: Why 77% of Global Lending Is Now Teetering on Edge - Michael Howell2 claims
- Patri Friedman on Seasteading 10/13/20081 claim
- Hash Power – Part 21 claim
and 12 more
Most important claims · 10 of 27Search all claims for “regulatory arbitrage” →
- Because financial-stability authority is split across many agencies with different funding and incentives that fight for position, financial institutions engage in regulatory arbitrage by seeking the weakest regulator, creating destructive competition among regulators; consolidating these agencies into one would reduce this problem.Eugene White on Bank Regulation
- Financial globalization has outrun the regulatory infrastructure needed to sustain it, and since a true global equivalent of domestic regulatory institutions is unattainable, the better path is a global financial system that permits much greater national diversity and discretion in rules (e.g., countries setting capital requirements at 10% or 20% per their own stability-innovation tradeoff), managing regulatory arbitrage by treating non-conforming cross-border financial flows the way we treat non-conforming toy imports—taxing or controlling them to preserve domestic regulatory integrity.Dani Rodrik on Globalization, Development, and Employment 04/11/2011
- The cycle of regulation and evasion in the drug system is the same regulatory arbitrage seen in financial regulation, where rules permitting financing of 'safe' assets created incentives to manufacture artificially safe instruments—the Triple-A securities that weren't actually safe and contributed to the 2008 financial meltdown.Robin Feldman on Drug Patents, Generics, and Drug Wars
- Manufacturers exploit the six-month window before Medicare-style price regulation applies to a new skin substitute product by launching, pricing high, withdrawing, and relaunching a slightly altered product, which keeps prices rising and illustrates the endless cat-and-mouse between regulators and firms.John Arnold - China, Energy Markets and Fixing America's Systems - [Invest Like the Best, EP.461]
- In the current system, stability rests primarily on safe assets (public debt/treasuries) as collateral, but the system also has a shadow banking wing focused on private debt instruments like collateralized loan obligations; this bifurcation creates instability and requires central banks to manage the system more actively.Collateral Crisis: Why 77% of Global Lending Is Now Teetering on Edge - Michael Howell
- The Wells Fargo fake-accounts scandal illustrates Hayek's point about local knowledge: management pressured employees to open many accounts, and only the front-line employees knew the specific circumstances of time and place, so they responded by opening accounts without telling customers—showing large organizations can fool themselves about what's happening on the front line.Tim Harford on the Virtues of Disorder and Messy
- Highly predictable tests get gamed: Volkswagen programmed cars to detect the fixed pattern of an emissions test and switch to a low-pollution mode, and banks bought narrowly targeted insurance that would pay off precisely in the Federal Reserve's stress-test scenarios with no commercial rationale—so in both cases a test that is tough in principle becomes meaningless in practice, the only difference being legality.Tim Harford on the Virtues of Disorder and Messy
- Because cancers and rare genetic diseases have high unmet need and lower evidence requirements for accelerated approval, companies invest disproportionately there, bypassing large Phase III trials that are needed in conditions with established standards of care like diabetes.Alex Telford - Unlocking Innovation in Pharma - [Invest Like the Best, EP.360]
- The FDA has a 'global stranglehold' on biotech development because most governments are unwilling to have regulations looser than the FDA's, and because US pharma markets pay more, most biotech is developed for the US market regardless of origin; regulatory arbitrage is much smaller than it appears.Peter Thiel on Political Theology | Conversations with Tyler
- If storing stablecoins required all the overhead of opening a bank account, they would lose much of their value; part of what is innovative about stablecoins is that a self-custody wallet lets anyone anywhere in the world open an account in a few minutes with just a smartphone, serving the unbanked and underbanked.Brian Armstrong